Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Cash flow provided by (used in) operating activities:
Net income	$ 721,175	$ 511,746
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization	35,283	34,093
Stock-based compensation	22,139	17,025
Loss from unconsolidated entities	3,285	9,735
Distributions of earnings from unconsolidated entities	25,412	30,447
Deferred tax provision	7,216	8,646
Impairment charges and write offs	35,400	36,773
Gain (Loss) on Sale of Assets	(5,042)	0
Other	(973)	2,371
Changes in operating assets and liabilities
Inventory	(679,337)	(299,940)
Origination of mortgage loans	(876,125)	(705,500)
Sale of mortgage loans	851,846	783,959
Receivables, prepaid expenses and other assets	(24,817)	4,233
Current income taxes, net	41,722	(127,199)
Customer deposits, net	(21,832)	(5,541)
Accounts payable and accrued expenses	16,692	(155,277)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	152,044	145,571
Cash flow (used in) provided by investing activities:
Purchase of property, construction and office equipment - net	(29,701)	(39,544)
Investments in and advances to unconsolidated entities	(99,568)	(117,221)
Return of investments in unconsolidated entities	29,302	48,564
Proceeds from the sale of assets	0	9,041
Other	(719)	0
Net Cash (Used in) Provided By Investing Activities, Continuing Operations	(100,686)	(99,160)
Cash flow used in financing activities:
Proceeds from loans payable	1,693,383	1,652,710
Payments of Debt Issuance Costs	0	(5,265)
Principal payments of loans payable	(1,771,103)	(1,771,636)
Repayments of Senior Debt	0	(400,000)
(Payments) proceeds from stock-based benefit plans	(3,540)	28,286
Purchase of treasury stock	(180,083)	(93,089)
Dividends paid	(47,069)	(46,306)
Proceeds from (Payments to) Noncontrolling Interests	167	0
Net Cash Used in Financing Activities, Continuing Operations	(308,245)	(635,300)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	(256,887)	(588,889)
Cash, Cash Equivalents, and Restricted Cash , beginning of period	1,344,341	1,398,550
Cash, Cash Equivalents, and Restricted Cash, end of period	$ 1,087,454	$ 809,661